A detailed history of Sei Investments CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Sei Investments CO holds 575,349 shares of CRL stock, worth $119 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
575,349
Previous 568,207 1.26%
Holding current value
$119 Million
Previous $134 Million 16.06%
% of portfolio
0.23%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$203.52 - $273.43 $1.45 Million - $1.95 Million
7,142 Added 1.26%
575,349 $156 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $18.2 Million - $26.4 Million
110,494 Added 24.14%
568,207 $134 Million
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $9.61 Million - $10.8 Million
-49,412 Reduced 9.74%
457,713 $89.7 Million
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $1.09 Million - $1.25 Million
5,947 Added 1.19%
507,125 $107 Million
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $12.8 Million - $17.4 Million
66,897 Added 15.4%
501,178 $101 Million
Q4 2022

Feb 10, 2023

BUY
$197.11 - $250.07 $292,117 - $370,603
1,482 Added 0.34%
434,281 $94.6 Million
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $44.2 Million - $60.8 Million
242,528 Added 127.46%
432,799 $85.2 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $19.5 Million - $28.8 Million
95,402 Added 100.56%
190,271 $40.7 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $282,083 - $399,769
1,104 Added 1.18%
94,869 $27 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $1.01 Million - $1.29 Million
-2,874 Reduced 2.97%
93,765 $35.4 Million
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $10.1 Million - $12.4 Million
-26,975 Reduced 21.82%
96,639 $39.8 Million
Q2 2021

Aug 06, 2021

SELL
$294.17 - $371.65 $4.05 Million - $5.12 Million
-13,771 Reduced 10.02%
123,614 $45.7 Million
Q1 2021

May 12, 2021

SELL
$249.67 - $299.48 $4.04 Million - $4.85 Million
-16,184 Reduced 10.54%
137,385 $39.6 Million
Q4 2020

Feb 08, 2021

SELL
$222.0 - $252.62 $2.96 Million - $3.37 Million
-13,348 Reduced 8.0%
153,569 $38.4 Million
Q3 2020

Dec 04, 2020

SELL
$175.56 - $226.45 $914,140 - $1.18 Million
-5,207 Reduced 3.03%
166,917 $37.8 Million
Q3 2020

Nov 06, 2020

SELL
$175.56 - $226.45 $2.96 Million - $3.82 Million
-16,856 Reduced 8.92%
172,124 $38.9 Million
Q2 2020

Aug 17, 2020

BUY
$118.84 - $189.72 $345,943 - $552,274
2,911 Added 1.56%
188,980 $32.9 Million
Q2 2020

Aug 11, 2020

SELL
$118.84 - $189.72 $2.17 Million - $3.47 Million
-18,293 Reduced 8.95%
186,069 $28.7 Million
Q1 2020

May 14, 2020

BUY
$98.9 - $178.34 $1.73 Million - $3.12 Million
17,468 Added 9.35%
204,362 $25.8 Million
Q4 2019

Feb 06, 2020

SELL
$126.05 - $152.76 $2.02 Million - $2.44 Million
-15,992 Reduced 7.88%
186,894 $28.4 Million
Q3 2019

Nov 12, 2019

BUY
$125.07 - $143.67 $557,812 - $640,768
4,460 Added 2.25%
202,886 $26.8 Million
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $512,356 - $616,779
4,152 Added 2.14%
198,426 $28.2 Million
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $280,288 - $392,356
-2,674 Reduced 1.36%
194,274 $28.2 Million
Q4 2018

Feb 13, 2019

SELL
$105.09 - $137.23 $573,055 - $748,315
-5,453 Reduced 2.69%
196,948 $26.2 Million
Q3 2018

Nov 08, 2018

BUY
$112.11 - $134.54 $2.81 Million - $3.37 Million
25,034 Added 14.11%
202,401 $27.2 Million
Q2 2018

Aug 03, 2018

BUY
$102.37 - $117.25 $1.29 Million - $1.48 Million
12,618 Added 7.66%
177,367 $19.9 Million
Q1 2018

May 11, 2018

SELL
$98.19 - $115.2 $438,025 - $513,907
-4,461 Reduced 2.64%
164,749 $17.6 Million
Q4 2017

Feb 08, 2018

BUY
$100.43 - $118.09 $566,425 - $666,027
5,640 Added 3.45%
169,210 $18.5 Million
Q3 2017

Nov 06, 2017

BUY
$96.72 - $109.26 $15.8 Million - $17.9 Million
163,570
163,570 $17.7 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.5B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.